vcvibes

Windham Capital Partners LLC

SEC exempt reporting adviser (venture capital exemption).

HQ
NY

Windham Capital Partners LLC invests in HealthTech companies, focusing on healthcare technologies that improve outcomes and lower costs. Adam Fine is Co-Founder, General Partner, and CEO. Its portfolio spans areas such as clinical-stage drug development, provider credentialing software, tele-mental health, and medical devices.

01 · Says / Does

TagSaysDoes
StagesNot statedNot enough dated deals
SectorsHealthtechNot enough dated deals
RegionsNot statedNot enough dated deals

Says: what the firm's funds state. Does: from 0 dated deals in the last 24 months.

02 · Fund history

FundYearSizeStatus
Windham Life Sciences Partners IV, L.P.

Windham Capital Partners invests in HealthTech companies, focusing on healthcare technologies that improve outcomes and lower costs. It backs people solving difficult problems and building category-defining products in healthcare, with companies that address large unmet needs in large markets. Inferred from the firm's website

2023$30.78M to $150M (Form D)Open, writing first checks

03 · People across funds

04 · Recent deals

No dated deals found yet.

05 · Latest from the firm

No news from the firm's website yet.

06 · Sources

  1. https://www.windhamcap.com
  2. https://www.windhamcap.com/contact
  3. https://www.windhamcap.com/portfolio
  4. https://www.windhamcap.com/
  5. https://www.windhamcap.com/team

Fund dates and sizes are from SEC Form D filings.

Last verified: Oct 28, 2026